Involvement of TonEBP/NFAT5 in osmoadaptative response of human retinal pigmented epithelial cells to hyperosmolar stress

• Published in: Molecular vision 2016-01, Vol.22, p.100-115
• Main Authors: Libert, Sarah, Willermain, François, Weber, Célia, Bryla, Angélic, Salik, Dany, Gregoire, Françoise, Bolaky, Nargis, Caspers, Laure, Perret, Jason, Delporte, Christine
• Format: Article
• Language: English
• Subjects: Blotting, Western; Cell Line; DNA Primers; Enzyme Inhibitors - pharmacology; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation - physiology; Humans; Imidazoles - pharmacology; Osmolar Concentration; Osmotic Pressure; Pyridines - pharmacology; Real-Time Polymerase Chain Reaction; Retinal Pigment Epithelium - metabolism; RNA, Messenger - genetics; Sodium Chloride - pharmacology; Transcription Factors - genetics; Transcription Factors - metabolism; Transfection
• ISSN: 1090-0535; 1090-0535

Macular edema, a frequently encountered complication of diabetic retinopathy (DR), results from alterations of the blood retinal barrier (BRB) and leads to modifications of the retinal pigmented epithelium (RPE) functions. Osmolar changes of the surrounding medium could be responsible for modifications of the RPE functions leading to disturbance of retinal homeostasis. The expression, activation and function of the key hyperosmolar response factor Tonicity Enhancer Binding Protein (TonEBP also called nuclear factor of activated T-cell 5 - NFTA5) was investigated in ARPE-19 cells, derived from human RPE, in response to hyperosmolar stimulation. ARPE-19 cells were exposed to hyperosmolar medium. TonEBP mRNA and protein levels were quantified by qRT-PCR and semi-quantitative Western blot. TonEBP nuclear translocation was investigated by immunofluorescence. TonEBP transactivation activity was measured using a reported plasmid containing TonEBP binding sites. In response to hyperosmolar stimulation of ARPE-19 cells, a dose-dependent increase in TonEBP mRNA and protein levels, as well as TonEBP nuclear translocation were observed. TonEBP transactivation activity was further demonstrated using a reporter plasmid containing TonEBP binding sites. A dominant negative form of TonEBP abolished NaCl-induced increase in TonEBP transactivation activity, and inhibited the increase of the target genes aldose reductase and sodium-dependent taurine transporter mRNA levels. SB203580, an inhibitor of two of the p38 protein kinase's isoforms (p38α and p38β) inhibited the TonEBP nuclear translocation and transactivation activity in ARPE-19 cells exposed to hyperosmolar stimulation. Our data demonstrates the involvement of TonEBP in the mechanisms responsible for osmoadaptation to hyperosmolar stress in RPE cells. Given the emerging role of TonEBP in different pathological pathways, these data open new perspectives for the analysis of the mechanisms involved in the modification of functions of the RPE during macular edema.